Journal articles on the topic 'Myocardial hypertrophy'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Myocardial hypertrophy.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Tang, Xin, Lihong Pan, Shuang Zhao, Feiyue Dai, Menglin Chao, Hong Jiang, Xuesong Li, et al. "SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)–Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome Activation." Circulation 141, no. 12 (March 24, 2020): 984–1000. http://dx.doi.org/10.1161/circulationaha.119.042336.
Full textXue, Honghong, Hongtao Shi, Fan Zhang, Hao Li, Chao Li, and Qinghua Han. "RIP3 Contributes to Cardiac Hypertrophy by Influencing MLKL-Mediated Calcium Influx." Oxidative Medicine and Cellular Longevity 2022 (April 14, 2022): 1–15. http://dx.doi.org/10.1155/2022/5490553.
Full textParker, Thomas G., and James N. Tsoporis. "Induction of S100β in Myocardium: An Intrinsic Inhibitor of Cardiac Hypertrophy." Canadian Journal of Applied Physiology 23, no. 4 (August 1, 1998): 377–89. http://dx.doi.org/10.1139/h98-022.
Full textTasnic, Mihail, Valeriu Revenco, and Ilia Catereniuc. "Correlations of myocardial bridges with left ventricle myocardial hypertrophy and prepontin coronary atherosclerosis." Moldovan Medical Journal 64, no. 5 (December 2021): 21–26. http://dx.doi.org/10.52418/moldovan-med-j.64-5.21.04.
Full textOuattara, Alexandre, Olivier Langeron, Rachid Souktani, Stéphane Mouren, Pierre Coriat, and Bruno Riou. "Myocardial and Coronary Effects of Propofol in Rabbits with Compensated Cardiac Hypertrophy." Anesthesiology 95, no. 3 (September 1, 2001): 699–707. http://dx.doi.org/10.1097/00000542-200109000-00024.
Full textLu, Dan, Jizheng Wang, Jing Li, Feifei Guan, Xu Zhang, Wei Dong, Ning Liu, Shan Gao, and Lianfeng Zhang. "Meox1 accelerates myocardial hypertrophic decompensation through Gata4." Cardiovascular Research 114, no. 2 (November 16, 2017): 300–311. http://dx.doi.org/10.1093/cvr/cvx222.
Full textChiu, Chiung-Zuan, Bao-Wei Wang, Tun-Hui Chung, and Kou-Gi Shyu. "Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes." Clinical Science 119, no. 7 (June 22, 2010): 273–82. http://dx.doi.org/10.1042/cs20100084.
Full textLiu, Xiuhua, Tianbo Li, Sheng Sun, Feifei Xu, and Yiguang Wang. "Role of myofibrillogenesis regulator-1 in myocardial hypertrophy." American Journal of Physiology-Heart and Circulatory Physiology 290, no. 1 (January 2006): H279—H285. http://dx.doi.org/10.1152/ajpheart.00247.2005.
Full textLv, Shichao, Qiang Wang, Meifang Wu, Meng Li, Xiaojing Wang, Ling Xu, and Junping Zhang. "QiShenYiQi Pill Improves Myocardial Hypertrophy Caused by Pressure Overload in Rats." Evidence-Based Complementary and Alternative Medicine 2021 (June 16, 2021): 1–10. http://dx.doi.org/10.1155/2021/5536723.
Full textZheng, Xi, Fuxiang Su, Ze Kang, Jingyuan Li, Chenyang Zhang, Yujia Zhang, and Liying Hao. "Analysis of Therapeutic Targets of A Novel Peptide Athycaltide-1 in the Treatment of Isoproterenol-Induced Pathological Myocardial Hypertrophy." Cardiovascular Therapeutics 2022 (May 2, 2022): 1–13. http://dx.doi.org/10.1155/2022/2715084.
Full textLiu, Yao-Lung, Chiu-Ching Huang, Chiz-Chung Chang, Che-Yi Chou, Shih-Yi Lin, I.-Kuan Wang, Dennis Jine-Yuan Hsieh, Gwo-Ping Jong, Chih-Yang Huang, and Chao-Min Wang. "Hyperphosphate-Induced Myocardial Hypertrophy through the GATA-4/NFAT-3 Signaling Pathway Is Attenuated by ERK Inhibitor Treatment." Cardiorenal Medicine 5, no. 2 (2015): 79–88. http://dx.doi.org/10.1159/000371454.
Full textNakamura, Teruya, Kunio Matsumoto, Shinya Mizuno, Yoshiki Sawa, Hikaru Matsuda, and Toshikazu Nakamura. "Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts." American Journal of Physiology-Heart and Circulatory Physiology 288, no. 5 (May 2005): H2131—H2139. http://dx.doi.org/10.1152/ajpheart.01239.2003.
Full textKoga, Kiyokazu, Agnes Kenessey, and Kaie Ojamaa. "Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy." American Journal of Physiology-Heart and Circulatory Physiology 304, no. 2 (January 15, 2013): H282—H293. http://dx.doi.org/10.1152/ajpheart.00595.2012.
Full textLeontyeva, I. V., N. V. Shcherbakova, E. P. Kalachanova, S. A. Thermosesov, and V. S. Sukhorukov. "Hypertrophic cardiomyopathy caused by mutations in the <I>PRKAG2</I> gene." Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 67, no. 4 (September 21, 2022): 99–107. http://dx.doi.org/10.21508/1027-4065-2022-67-4-99-107.
Full textJi, Xiao-Bing, Xiu-Rong Li, Hao-Ding, Qi Sun, Yang Zhou, Ping Wen, Chun-Sun Dai, and Jun-Wei Yang. "Inhibition of Uncoupling Protein 2 Attenuates Cardiac Hypertrophy Induced by Transverse Aortic Constriction in Mice." Cellular Physiology and Biochemistry 36, no. 5 (2015): 1688–98. http://dx.doi.org/10.1159/000430142.
Full textChernykh, N. Yu, A. A. Tarasova, O. S. Groznova, and I. M. Shigabeev. "Left ventricular myocardial strain and electrocardiographic changes in children with hypertrophic cardiomyopathy." Meditsinskiy sovet = Medical Council, no. 11 (August 12, 2021): 124–32. http://dx.doi.org/10.21518/2079-701x-2021-11-124-132.
Full textAluja, David, Sara Delgado-Tomás, Marisol Ruiz-Meana, José A. Barrabés, and Javier Inserte. "Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy." International Journal of Molecular Sciences 23, no. 8 (April 7, 2022): 4103. http://dx.doi.org/10.3390/ijms23084103.
Full textWang, Hui, Yuqin Zhang, Shuwen Guo, Jiani Wu, Wang’ou Lin, Binyue Zhang, Pengfei Feng, et al. "Effects of Yiqi Huoxue Decoction on Post-Myocardial Infarction Cardiac Nerve Remodeling and Cardiomyocyte Hypertrophy in Rats." Evidence-Based Complementary and Alternative Medicine 2021 (August 21, 2021): 1–16. http://dx.doi.org/10.1155/2021/5168574.
Full textChen, Chao-Yi, Jyh-Gang Leu, Kuan-Yu Lin, Chin-Yu Shih, and Yao-Jen Liang. "Serotonin receptor subtype-2B signaling is associated with interleukin-18-induced cardiomyoblast hypertrophy in vitro." Asian Biomedicine 16, no. 2 (April 1, 2022): 79–87. http://dx.doi.org/10.2478/abm-2022-0010.
Full textXia, Huiting, Aqeela Zahra, Meng Jia, Qun Wang, Yunfu Wang, Susan L. Campbell, and Jianping Wu. "Na+/H+ Exchanger 1, a Potential Therapeutic Drug Target for Cardiac Hypertrophy and Heart Failure." Pharmaceuticals 15, no. 7 (July 15, 2022): 875. http://dx.doi.org/10.3390/ph15070875.
Full textBishop, Sanford P. "The Myocardial Cell: Normal Growth, Cardiac Hypertrophy and Response to Injury." Toxicologic Pathology 18, no. 4a (January 1990): 438–53. http://dx.doi.org/10.1177/0192623390004part_102.
Full textNakata, Yohei, Muneo Yoshibayashi, Toshiya Yonemura, Shinji Uemoto, Yukihiro Inomata, Koichi Tanaka, and Kenshi Furusho. "TACROLIMUS AND MYOCARDIAL HYPERTROPHY." Transplantation 69, no. 9 (May 2000): 1960–62. http://dx.doi.org/10.1097/00007890-200005150-00039.
Full textSuzuki, Jun-ichi, Hiroki Sato, Makoto Kaneko, Asuka Yoshida, Norio Aoyama, Shouta Akimoto, Kouji Wakayama, et al. "Periodontitis and myocardial hypertrophy." Hypertension Research 40, no. 4 (November 10, 2016): 324–28. http://dx.doi.org/10.1038/hr.2016.146.
Full textNakagami, Hironori, and James K. Liao. "Statins and myocardial hypertrophy." Coronary Artery Disease 15, no. 5 (August 2004): 247–50. http://dx.doi.org/10.1097/01.mca.0000130229.18685.b9.
Full textSugden, Peter H. "Signaling in Myocardial Hypertrophy." Circulation Research 84, no. 6 (April 2, 1999): 633–46. http://dx.doi.org/10.1161/01.res.84.6.633.
Full textHirsch, Alan T., John A. Opsahl, Mary M. Lunzer, and Stephen A. Katz. "Active renin and angiotensinogen in cardiac interstitial fluid after myocardial infarction." American Journal of Physiology-Heart and Circulatory Physiology 276, no. 6 (June 1, 1999): H1818—H1826. http://dx.doi.org/10.1152/ajpheart.1999.276.6.h1818.
Full textChen, Yintao, Ye Chang, Naijin Zhang, Xiaofan Guo, Guozhe Sun, and Yingxian Sun. "Atorvastatin Attenuates Myocardial Hypertrophy in Spontaneously Hypertensive Rats via the C/EBPβ/PGC-1α/UCP3 Pathway." Cellular Physiology and Biochemistry 46, no. 3 (2018): 1009–18. http://dx.doi.org/10.1159/000488832.
Full textHan, Jibo, Shanshan Dai, Lingfeng Zhong, Xiaowen Shi, Xiaoxi Fan, Xin Zhong, Wante Lin, et al. "GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) Axis." Hypertension 79, no. 11 (November 2022): 2505–18. http://dx.doi.org/10.1161/hypertensionaha.122.20004.
Full textShen, Linyuan, Mailin Gan, Zhengdong Tan, Dongmei Jiang, Yanzhi Jiang, Mingzhou Li, Jinyong Wang, Xuewei Li, Shunhua Zhang, and Li Zhu. "A Novel Class of tRNA-Derived Small Non-Coding RNAs Respond to Myocardial Hypertrophy and Contribute to Intergenerational Inheritance." Biomolecules 8, no. 3 (July 16, 2018): 54. http://dx.doi.org/10.3390/biom8030054.
Full textTsuda, Takeshi. "Clinical Assessment of Ventricular Wall Stress in Understanding Compensatory Hypertrophic Response and Maladaptive Ventricular Remodeling." Journal of Cardiovascular Development and Disease 8, no. 10 (September 29, 2021): 122. http://dx.doi.org/10.3390/jcdd8100122.
Full textDung, Van Hung, Pham Thanh Binh, Nguyen Tien Hoa, and Bui Minh Trang. "Case report: Bilateral hypertrophic obstructive cardiomyophathy associated with myocardial bridge." Tạp chí Phẫu thuật Tim mạch và Lồng ngực Việt Nam 39 (October 31, 2022): 122–25. http://dx.doi.org/10.47972/vjcts.v39i.810.
Full textTennant, Bryn. "Small Animal Review." Companion Animal 25, no. 5 (June 2, 2020): 110. http://dx.doi.org/10.12968/coan.2020.0043.
Full textStrøm, Claes C., Mogens Kruhøffer, Steen Knudsen, Frank Stensgaard-Hansen, Thomas E. N. Jonassen, Torben F. Ørntoft, Stig Haunsø, and Søren P. Sheikh. "Identification of a Core Set of Genes That Signifies Pathways Underlying Cardiac Hypertrophy." Comparative and Functional Genomics 5, no. 6-7 (2004): 459–70. http://dx.doi.org/10.1002/cfg.428.
Full textLorén, Christina, Christen Dahl, Lan Do, Vibeke Almaas, Odd Geiran, Stellan Mörner, and Urban Hellman. "Low Molecular Mass Myocardial Hyaluronan in Human Hypertrophic Cardiomyopathy." Cells 8, no. 2 (January 29, 2019): 97. http://dx.doi.org/10.3390/cells8020097.
Full textBasargina, E. N., V. S. Ermolenko, and I. V. Sil’nova. "Myocardial hypertrophy in infants in pediatric practice." Kazan medical journal 96, no. 4 (August 15, 2015): 647–53. http://dx.doi.org/10.17750/kmj2015-647.
Full textZhu, Huiping, Liutong Pan, Yuanting Dai, Dan Zheng, and Shasha Cai. "Role of TLR4/MyD88 Signaling Pathway in the Occurrence and Development of Uremia-Induced Myocardial Hypertrophy and Possible Mechanism." Evidence-Based Complementary and Alternative Medicine 2021 (October 13, 2021): 1–9. http://dx.doi.org/10.1155/2021/7883643.
Full textCalamaras, Timothy D., Robert A. Baumgartner, Mark J. Aronovitz, Angela L. McLaughlin, Kelly Tam, Daniel A. Richards, Craig W. Cooper, et al. "Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload." American Journal of Physiology-Heart and Circulatory Physiology 316, no. 1 (January 1, 2019): H145—H159. http://dx.doi.org/10.1152/ajpheart.00029.2018.
Full textZhao, Mingyue, Lihui Lu, Song Lei, Hua Chai, Siyuan Wu, Xiaoju Tang, Qinxue Bao, Li Chen, Wenchao Wu, and Xiaojing Liu. "Inhibition of Receptor Interacting Protein Kinases Attenuates Cardiomyocyte Hypertrophy Induced by Palmitic Acid." Oxidative Medicine and Cellular Longevity 2016 (2016): 1–13. http://dx.doi.org/10.1155/2016/1451676.
Full textMing, Sitong, Mo Kan, Liu Liu, Zhuang Zhang, Xiaoran Liu, Yaxin Liu, Zhen Li, et al. "Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA." Evidence-Based Complementary and Alternative Medicine 2022 (September 7, 2022): 1–17. http://dx.doi.org/10.1155/2022/3188292.
Full textSharma, Jayendra, William Hellenbrand, Charles Kleinman, and Ralph Mosca. "Symptomatic myocardial bridges in children: a case report with review of literature." Cardiology in the Young 21, no. 5 (June 23, 2011): 490–94. http://dx.doi.org/10.1017/s1047951111000849.
Full textJain, Mohit, Ronglih Liao, Bruno K. Podesser, Soeun Ngoy, Carl S. Apstein, and Franz R. Eberli. "Influence of gender on the response to hemodynamic overload after myocardial infarction." American Journal of Physiology-Heart and Circulatory Physiology 283, no. 6 (December 1, 2002): H2544—H2550. http://dx.doi.org/10.1152/ajpheart.00338.2002.
Full textKatz, Stephen A., John A. Opsahl, Shane E. Wernsing, Lynn M. Forbis, Juline Smith, and Lois J. Heller. "Myocardial renin is neither necessary nor sufficient to initiate or maintain ventricular hypertrophy." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 278, no. 3 (March 1, 2000): R578—R586. http://dx.doi.org/10.1152/ajpregu.2000.278.3.r578.
Full textSarkar, Sagartirtha, Douglas W. Leaman, Sudhiranjan Gupta, Parames Sil, David Young, Annitta Morehead, Debabrata Mukherjee, et al. "Cardiac Overexpression of Myotrophin Triggers Myocardial Hypertrophy and Heart Failure in Transgenic Mice." Journal of Biological Chemistry 279, no. 19 (February 16, 2004): 20422–34. http://dx.doi.org/10.1074/jbc.m308488200.
Full textLiu, Lei, Chao Wang, Dianjun Sun, Shuangquan Jiang, Hong Li, Weihua Zhang, Yajun Zhao, et al. "Calhex231 Ameliorates Cardiac Hypertrophy by Inhibiting Cellular Autophagy in Vivo and in Vitro." Cellular Physiology and Biochemistry 36, no. 4 (2015): 1597–612. http://dx.doi.org/10.1159/000430322.
Full textIswara, Raja Al Fath Widya, Arif Rahman Sadad, Intarniati Nur Rohmah, and Sigid Kirana Lintang Bhima. "Kematian Mendadak Akibat Kardiomiopati Hipertrofi Pada Dewasa Muda." Medica Hospitalia : Journal of Clinical Medicine 7, no. 2 (November 19, 2020): 470–75. http://dx.doi.org/10.36408/mhjcm.v7i2.522.
Full textSui, Xin, Na Li, Xiaozheng Shi, Xiaohua Li, Dong Han, Zhidong Qiu, Yue Deng, and Guangwei Sun. "Pinocembrin Protects Cardiomyocytes Against Isoproterenol-Induced Hypertrophy." Natural Product Communications 16, no. 8 (August 2021): 1934578X2110332. http://dx.doi.org/10.1177/1934578x211033216.
Full textGarcía-Díaz, Lutgardo, Félix Coserria, and Guillermo Antiñolo. "Hypertrophic Cardiomyopathy due to Mitochondrial Disease: Prenatal Diagnosis, Management, and Outcome." Case Reports in Obstetrics and Gynecology 2013 (2013): 1–4. http://dx.doi.org/10.1155/2013/472356.
Full textBupha-Intr, Tepmanas, Jeffrey W. Holmes, and Paul M. L. Janssen. "Induction of hypertrophy in vitro by mechanical loading in adult rabbit myocardium." American Journal of Physiology-Heart and Circulatory Physiology 293, no. 6 (December 2007): H3759—H3767. http://dx.doi.org/10.1152/ajpheart.01267.2006.
Full textMorgan, Howard E. "Signal transduction in myocardial hypertrophy." Keio Journal of Medicine 39, no. 1 (1990): 1–5. http://dx.doi.org/10.2302/kjm.39.1.
Full textZhang, Jianyi. "Myocardial Energetics In Cardiac Hypertrophy." Clinical and Experimental Pharmacology and Physiology 29, no. 4 (April 2002): 351–59. http://dx.doi.org/10.1046/j.1440-1681.2002.03657.x.
Full text